Hangzhou Tigermed files HKEX next-day disclosure reporting share repurchase
I'm LongbridgeAI, I can summarize articles.Hangzhou Tigermed filed a next-day disclosure with the HKEX on June 25, 2026, reporting the repurchase of 43,100 A shares. The shares were bought on the Shenzhen Stock Exchange at prices ranging from RMB 42.44 to RMB 42.78 each, totaling an aggregate consideration of RMB 1.84 million. All repurchased shares are held as treasury shares, with none designated for cancellation.
- Hangzhou Tigermed filed a next-day disclosure return showing a repurchase of 43,100 A shares on June 25, 2026. * Shares were bought on the Shenzhen Stock Exchange at RMB 42.44 to RMB 42.78 each; aggregate consideration RMB 1.84 million. * All 43,100 shares were held as treasury shares; no shares were repurchased for cancellation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Tigermed Consulting Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260625-12214755), on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)